TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2152944

Group type: EXPERIMENTAL
Intervention: In vitro best regimen (IVBR), a three-drug combination of proved efficacy in SCLC, administered as secondary therapy to patients with partial or no responses after primary therapy.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Empiric combination of vincristine-doxorubicin-cyclophosphamide, administered as secondary therapy when DST data were unavailable.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Primary therapy with etoposide and cisplatin, followed by restaging after 12 weeks.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: In vitro drug sensitivity testing (DST) data used to select chemotherapy.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: IVBR as secondary therapy.
Number of subjects: 80
Study: 359121

Group type: EXPERIMENTAL
Intervention: 5FU infusion with Mitomycin-C
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5FU infusion with Methyl-CCNU
Number of subjects: 0
Study: 31078338

Group type: EXPERIMENTAL
Intervention: BPI surgery patients
Number of subjects: 1936

Group type: EXPERIMENTAL
Intervention: Opioid-naive BPI patients
Number of subjects: 1936

Group type: COMPARATOR
Intervention: Control group (non-BPI patients)
Number of subjects: 1936
Study: 29408760

Group type: EXPERIMENTAL
Intervention: Zataria multiflora 5 mg/kg/day
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Zataria multiflora 10 mg/kg/day
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 27578482

Group type: EXPERIMENTAL
Intervention: HFNC (High Flow Nasal Cannula)
Number of subjects: 0
Study: 25348614

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention consisting of transplant education and engagement activities targeting dialysis facility leadership, staff, and patients.
Number of subjects: 134

Group type: COMPARATOR
Intervention: Standard of care or 'usual' transplant education.
Number of subjects: 134
Study: 22354664

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO2) at 3 ATA for 10 consecutive days
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO2)
Number of subjects: 1

Group type: COMPARATOR
Intervention: High pressure (up to 3 ATA) alone
Number of subjects: 1

Group type: COMPARATOR
Intervention: Pure oxygen alone
Number of subjects: 1
Study: 19818077

Group type: COMPARATOR
Intervention: Solifenacin 5 mg once daily (od) alone
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg od combined with simplified bladder training
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Solifenacin 10 mg od (after dose increase)
Number of subjects: 643
Study: 17605004

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tramadol 200 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tramadol 400 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Naloxone 0.1 mg IM
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Naloxone 0.2 mg IM
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Morphine 15 mg IM
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Morphine 30 mg IM
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 17056608

Group type: EXPERIMENTAL
Intervention: Enhanced pharmacy review
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Community physiotherapy
Number of subjects: 325

Group type: COMPARATOR
Intervention: Control (advice leaflet reinforced by telephone call)
Number of subjects: 325
Study: 12064335

Group type: EXPERIMENTAL
Intervention: Induced changes in coffee consumption
Number of subjects: 214
Study: 10359389

Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 4075

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 4075

Group type: EXPERIMENTAL
Intervention: Sulfonylurea
Number of subjects: 4075

Group type: EXPERIMENTAL
Intervention: Metformin (in obese patients)
Number of subjects: 4075
Study: 8530606

Group type: EXPERIMENTAL
Intervention: Sandostatin LAR 20 mg
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sandostatin LAR 30 mg
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sandostatin LAR (3, 6, 9, or 12 mg)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sandostatin LAR
Number of subjects: 29
Study: 1779103

Group type: EXPERIMENTAL
Intervention: Gel‐Larmes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chondroitin sulphate eye drops
Number of subjects: 0
Study: 6123069

Group type: EXPERIMENTAL
Intervention: Combination of Dihydergot (0.25 mg i.v.) and etilefrine (15 mg p.o.)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Combination of Dihydergot (2 mg) and etilefrine (20 mg)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Etilefrine (20 mg)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Dihydergot (2 mg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo (0.25 Dihydergot i.v.)
Number of subjects: 29
Study: 31369841

Group type: EXPERIMENTAL
Intervention: Placebo mouthwash
Number of subjects: 23

Group type: COMPARATOR
Intervention: Antibacterial mouthwash
Number of subjects: 23
Study: 28826740

Group type: EXPERIMENTAL
Intervention: Parnaparin sodium (low-molecular weight heparin) for the whole cycle
Number of subjects: 247

Group type: COMPARATOR
Intervention: Routine hormonal therapy only
Number of subjects: 247
Study: 25573831

Group type: EXPERIMENTAL
Intervention: MRA-naïve patients
Number of subjects: 842

Group type: EXPERIMENTAL
Intervention: MRA-treated patients
Number of subjects: 842

Group type: EXPERIMENTAL
Intervention: Subgroup with low cortisol and high aldosterone
Number of subjects: 842

Group type: COMPARATOR
Intervention: Total cohort
Number of subjects: 842
Study: 24075374

Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI) combined with ovarian stimulation
Number of subjects: 703

Group type: COMPARATOR
Intervention: Control group (unexplained infertility)
Number of subjects: 703
Study: 21419287

Group type: EXPERIMENTAL
Intervention: Buccal infiltration of 4% articaine with 1:100,000 epinephrine
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Buccal infiltration of 1 mL/30 mg of ketorolac tromethamine (after 0.9 mL of 4% articaine)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Supplemental buccal infiltration of 1 mL/4 mg of dexamethasone
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (no supplemental infiltration)
Number of subjects: 94
Study: 19548436

Group type: EXPERIMENTAL
Intervention: Qihong Decoction (QHD) combined with routine treatment
Number of subjects: 72

Group type: COMPARATOR
Intervention: Routine treatment alone
Number of subjects: 72
Study: 16787719

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/day) for 6 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 40
Study: 14747233

Group type: EXPERIMENTAL
Intervention: rosiglitazone 4 mg b.i.d. for 12 weeks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: rosiglitazone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: rosiglitazone with co-infusion of exogenous insulin
Number of subjects: 12

Group type: COMPARATOR
Intervention: nateglinide 60 mg b.i.d. for 12 weeks
Number of subjects: 12
Study: 10381039

Group type: EXPERIMENTAL
Intervention: Dynamic strength training (EG) 2 times a week with moderate loads of 50-70% of repetition maximum.
Number of subjects: 65

Group type: COMPARATOR
Intervention: Recreational physical activities and range of motion exercises (CG).
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Dynamic strength training (EG).
Number of subjects: 65
Study: 8674257

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 1908192

Group type: EXPERIMENTAL
Intervention: Infusion of epidural diamorphine at a rate of 1 mg/hour (group 1)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Bolus doses of epidural diamorphine 5 mg on demand (group 2)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22
Study: 6345330

Group type: EXPERIMENTAL
Intervention: BCAAs (40 gm per day) in 5% glucose
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (5% glucose)
Number of subjects: 50
Study: 29998740

Group type: EXPERIMENTAL
Intervention: Remaking Recess with implementation support
Number of subjects: 31

Group type: COMPARATOR
Intervention: Remaking Recess (without implementation support)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both groups (Remaking Recess and Remaking Recess with implementation support)
Number of subjects: 31
Study: 28958424

Group type: EXPERIMENTAL
Intervention: Slow work pace
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fast work pace
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Active pauses
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Passive pauses
Number of subjects: 18
Study: 25619917

Group type: EXPERIMENTAL
Intervention: Highlighted prompts
Number of subjects: 4

Group type: COMPARATOR
Intervention: Not highlighted prompts
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: High-priority highlighted prompts
Number of subjects: 4

Group type: COMPARATOR
Intervention: High-priority prompts from the previous year (not highlighted)
Number of subjects: 4
Study: 22549655

Group type: EXPERIMENTAL
Intervention: Manual needle placement (n=42)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Electrical stimulation guidance (n=39)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Gastrocnemius medialis
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Gastrocnemius lateralis
Number of subjects: 81
Study: 20046181

Group type: EXPERIMENTAL
Intervention: Immunochromatographic test (ICT) for antigen
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Immunochromatographic test (ICT) for antibody
Number of subjects: 98

Group type: COMPARATOR
Intervention: Microscopic examination of peripheral blood film
Number of subjects: 98
Study: 19040391

Group type: EXPERIMENTAL
Intervention: Ayurvedic formulation 'varuna and banana stem' (active treatment)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 77
Study: 16077391

Group type: EXPERIMENTAL
Intervention: On-pump surgery
Number of subjects: 35

Group type: COMPARATOR
Intervention: Off-pump surgery
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study: 12459689

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 10509459

Group type: EXPERIMENTAL
Intervention: Direct palpation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional instruments
Number of subjects: 20

Group type: COMPARATOR
Intervention: Laparoscopic instruments
Number of subjects: 20
Study: 8934383

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 1755059

Group type: EXPERIMENTAL
Intervention: ivermectin
Number of subjects: 1745

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1745
Study: 6580659

Group type: EXPERIMENTAL
Intervention: Piridoxilate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 30080432

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 16
Study: 30043092

Group type: EXPERIMENTAL
Intervention: Vitamin D3 70 micro g/day (2800 IU/day)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 26836465

Group type: EXPERIMENTAL
Intervention: Cognitive aid available (7 of 13 groups)
Number of subjects: 13

Group type: COMPARATOR
Intervention: No cognitive aid available (6 of 13 groups)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: All groups (13 groups)
Number of subjects: 13
Study: 24563518

Group type: EXPERIMENTAL
Intervention: Visual inspection with acetic acid (VIA) screening by primary health workers
Number of subjects: 151538

Group type: COMPARATOR
Intervention: Control group (cancer education offered once)
Number of subjects: 151538
Study: 22215183

Group type: EXPERIMENTAL
Intervention: 50,000 IU vitamin D3 monthly
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 50,000 IU vitamin D3 alternate months
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Single 50,000 IU dose pre-departure
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: All regimens
Number of subjects: 110
Study: 20177280

Group type: EXPERIMENTAL
Intervention: Contraceptive vaginal ring
Number of subjects: 273

Group type: COMPARATOR
Intervention: Oral contraceptive pill (OCP)
Number of subjects: 273
Study: 17394627

Group type: EXPERIMENTAL
Intervention: Biatain-Ibu non adhesive foam dressing with ibuprofen
Number of subjects: 122

Group type: COMPARATOR
Intervention: Biatain non adhesive foam without ibuprofen
Number of subjects: 122
Study: 17975958

Group type: EXPERIMENTAL
Intervention: Low-power laser irradiation (780 nm; power, 250 mW)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (non-active light: diffused LED lamp)
Number of subjects: 18
Study: 15487437

Group type: EXPERIMENTAL
Intervention: Syllogisms with a causal conditional premise that can be extended by an agency premise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control content syllogisms
Number of subjects: 0
Study: 10671963

Group type: EXPERIMENTAL
Intervention: Nels cream (containing chloroxylenol and zinc oxide)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 5% benzoyl peroxide cream
Number of subjects: 41

Group type: COMPARATOR
Intervention: Vehicle of the Nels cream
Number of subjects: 41
Study: 9091691

Group type: EXPERIMENTAL
Intervention: Brief physician advice (two 10- to 15-minute counseling visits using a scripted workbook)
Number of subjects: 723

Group type: COMPARATOR
Intervention: Control group (no brief physician advice)
Number of subjects: 723
Study: 1552408

Group type: EXPERIMENTAL
Intervention: Inhalation of nebulized cromolyn sodium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 0
Study: 4053214

Group type: EXPERIMENTAL
Intervention: Lenampicillin (LAPC) - single dose (250 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Amoxicillin (AMPC) - single dose (500 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Lenampicillin (LAPC) - multiple dose (250 mg twice a day for 8 days)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Amoxicillin (AMPC) - multiple dose (500 mg twice a day for 8 days)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Lenampicillin (LAPC)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Amoxicillin (AMPC)
Number of subjects: 6
Study: 31441936

Group type: EXPERIMENTAL
Intervention: Constant financial incentive ($0.00020 per step)
Number of subjects: 3515

Group type: EXPERIMENTAL
Intervention: Decreasing financial incentive ($0.00020 per step)
Number of subjects: 3515

Group type: EXPERIMENTAL
Intervention: Increasing financial incentive ($0.00020 per step)
Number of subjects: 3515

Group type: COMPARATOR
Intervention: Control group ($0.00001 per step)
Number of subjects: 3515
Study: 29466159

Group type: EXPERIMENTAL
Intervention: Aspirin (81 mg daily)
Number of subjects: 3424

Group type: COMPARATOR
Intervention: Rivaroxaban (10 mg daily for 5 days, then continued or switched to aspirin)
Number of subjects: 3424
Study: 25524327

Group type: EXPERIMENTAL
Intervention: 60 µg/day selenium
Number of subjects: 230

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study: 24381263

Group type: EXPERIMENTAL
Intervention: Motor beta synchrony (MBS) reduction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher incentives
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MBS reduction at the beginning of rest periods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incentive effects on MBS reduction and rest duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MBS reduction
Number of subjects: 0
Study: 21617159

Group type: EXPERIMENTAL
Intervention: Point-of-care panel assessment of CK-MB(mass), myoglobin, and troponin
Number of subjects: 2243

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 2243
Study: 20068435

Group type: EXPERIMENTAL
Intervention: Sonography-guided injection of botulinum toxin A into calf muscles
Number of subjects: 32

Group type: COMPARATOR
Intervention: Electric stimulation-guided injection of botulinum toxin A into calf muscles
Number of subjects: 32
Study: 17105841

Group type: EXPERIMENTAL
Intervention: Simvastatin + OCP
Number of subjects: 48

Group type: COMPARATOR
Intervention: OCP alone
Number of subjects: 48
Study: 16232016

Group type: EXPERIMENTAL
Intervention: Fat emulsion administered through the ECMO circuit (1-3 g/kg/day)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Fat emulsion administered through separate intravenous access (1-3 g/kg/day)
Number of subjects: 9
Study: 12070007

Group type: EXPERIMENTAL
Intervention: Cyclosporine plus prednisone
Number of subjects: 287

Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 287
Study: 9810316

Group type: EXPERIMENTAL
Intervention: Short-course preoperative radiation therapy
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Adjuvant radiotherapy with conventional doses and concurrent fluorouracil-based chemotherapy
Number of subjects: 1168

Group type: EXPERIMENTAL
Intervention: Neoadjuvant radiochemotherapy
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Postoperative combination therapy
Number of subjects: 1168
Study: 11362207

Group type: EXPERIMENTAL
Intervention: ABT-538 (300 mg, 400 mg, 500 mg, or 600 mg, administered twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2624830

Group type: EXPERIMENTAL
Intervention: 0.5% bupivicaine (Marcain) ilioinguinal nerve block
Number of subjects: 60

Group type: COMPARATOR
Intervention: No bupivicaine (Control Group B)
Number of subjects: 60
Study: 979871

Group type: EXPERIMENTAL
Intervention: Exercise group (bicycle ergometer training for 15 minutes, 3 times weekly at 140 bpm)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 30986535

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Oral naltrexone (O-NTX)
Number of subjects: 237
Study: 28818854

Group type: EXPERIMENTAL
Intervention: nMDZ (midazolam)
Number of subjects: 60

Group type: COMPARATOR
Intervention: nKTM (ketamine)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: nMDZ (midazolam) and nKTM (ketamine)
Number of subjects: 60
Study: 26940112

Group type: EXPERIMENTAL
Intervention: Recovery-focused Cognitive Behavioural Therapy for Older Adults (RfCBT-OA) plus treatment as usual (TAU)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 50
Study: 24698798

Group type: EXPERIMENTAL
Intervention: Optimally-medicated (ON meds) during split-belt treadmill (SBT) walking
Number of subjects: 10

Group type: COMPARATOR
Intervention: Withholding dopaminergic medication (OFF meds) during split-belt treadmill (SBT) walking
Number of subjects: 10
Study: 22369555

Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing (treatment group, n = 22)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No periodontal treatment (control group, n = 18)
Number of subjects: 40
Study: 20869984

Group type: EXPERIMENTAL
Intervention: Maintenance-tailored therapy (MTT)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Standard behavior therapy (SBT)
Number of subjects: 213
Study: 17942759

Group type: EXPERIMENTAL
Intervention: 80 mg atorvastatin
Number of subjects: 10001

Group type: COMPARATOR
Intervention: 10 mg atorvastatin
Number of subjects: 10001
Study: 15827447

Group type: EXPERIMENTAL
Intervention: Rabeprazole (20 mg or 10 mg) once daily for up to 5 years
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg) once daily for up to 5 years
Number of subjects: 243

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 243
Study: 12789464

Group type: EXPERIMENTAL
Intervention: RC + CT + A (radiochemotherapy plus amifostine)
Number of subjects: 56

Group type: COMPARATOR
Intervention: RC + CT (radiochemotherapy alone)
Number of subjects: 56
Study: 10364989

Group type: EXPERIMENTAL
Intervention: Gelatin
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Low molecular weight hydroxyethyl starch (HES)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 42
Study: 8913472

Group type: EXPERIMENTAL
Intervention: Topical 2% erythromycin
Number of subjects: 225

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 225
Study: 1882922

Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Argon laser
Number of subjects: 20
Study: 6760123

Group type: EXPERIMENTAL
Intervention: Dibekacin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Gentamicin
Number of subjects: 30
Study: 30900426

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy (SCIT) with Fagales pollen extracts
Number of subjects: 56

Group type: COMPARATOR
Intervention: No treatment (Control group)
Number of subjects: 56
Study: 29645365

Group type: EXPERIMENTAL
Intervention: Preprocedural ultrasound (US)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Palpation method
Number of subjects: 80
Study: 26849094

Group type: EXPERIMENTAL
Intervention: McGrath® Series 5 videolaryngoscope
Number of subjects: 49

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 49
Study: 24213960

Group type: EXPERIMENTAL
Intervention: Endurance Training
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Precision Training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Both types of training
Number of subjects: 22
Study: 23173418

Group type: EXPERIMENTAL
Intervention: HIFU treatment at 3.5 W in group A
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: HIFU treatment at 4.0 W in group B
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: HIFU treatment at 4.5 W in group C
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group D (no treatment)
Number of subjects: 80
Study: 21155091

Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 286

Group type: COMPARATOR
Intervention: PCV7
Number of subjects: 286
Study: 17414813

Group type: EXPERIMENTAL
Intervention: Exercise withdrawal (N=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (continued regular aerobic exercise, N=20)
Number of subjects: 40